Entero Therapeutics, Inc. Announces Corporate Name Change to GridAI Technologies Corp. and New Ticker Symbol "GRDX"

Rhea-AI Summary

Entero Therapeutics (NASDAQ:ENTO) will change its name to GridAI Technologies Corp. and its ticker to GRDX, effective at 12:01 AM/ET on December 1, 2025. The change follows the Company's acquisition of 100% of GRID AI Corp, a grid-edge AI software and controls platform for utilities, retail energy providers, and large power users. The Company's common stock will begin trading on the Nasdaq Capital Market under the new name and symbol on December 1, 2025. The company said the name and ticker changes do not alter its legal structure, operations, or financial reporting, and shareholders are not required to take any action.

Positive

• Acquired 100% of GRID AI Corp
• Name change effective 12:01 ET, Dec 1, 2025
• Ticker GRDX begins trading on Nasdaq Dec 1, 2025

Negative

• None.

News Market Reaction – ENTO

+5.28% 2.6x vol

13 alerts

+5.28% News Effect

+44.5% Peak in 1 hr 38 min

+$631K Valuation Impact

$13M Market Cap

2.6x Rel. Volume

On the day this news was published, ENTO gained 5.28%, reflecting a notable positive market reaction. Argus tracked a peak move of +44.5% during that session. Our momentum scanner triggered 13 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $631K to the company's valuation, bringing the market cap to $13M at that time. Trading volume was elevated at 2.6x the daily average, suggesting notable buying interest.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Acquired ownership: 100% Price change: 5.28% Current price: $2.99 +2 more

5 metrics

Acquired ownership 100% Ownership of GRID AI Corp following acquisition

Price change 5.28% 24h move prior to publication on Nov 28, 2025

Current price $2.99 Last close before name and ticker change news

52-week range $0.9693–$5.84 Low and high over the last 52 weeks

Relative volume 6.96x Today’s volume vs 20-day average

Market Reality Check

Price: $2.99 Vol: Volume 896,051 vs 20-day ...

high vol

$2.99 Last Close

Volume Volume 896,051 vs 20-day average 128,725 (about 7x typical activity). high

Technical Price $2.99 is trading above the 200-day MA at $2.24 and 48.8% below the 52-week high.

Peers on Argus

ENTO gained 5.28% while momentum peers were mixed: QNRX up 6.87%, SLXN down 4.61...

1 Up 2 Down

ENTO gained 5.28% while momentum peers were mixed: QNRX up 6.87%, SLXN down 4.61%, REVB down 5.05%. Broader biotech dynamics are present, but moves do not align directionally with ENTO.

Historical Context

5 past events · Latest: Nov 28 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Nov 28	Name/ticker change	Positive	+5.3%	Corporate rebrand to GridAI Technologies and new Nasdaq ticker GRDX.
Nov 19	Customer LOI	Positive	-19.9%	LOI with hyperscaler AI data-center developer outlining multi-year revenue ramp.
Nov 13	Leadership expansion	Positive	-4.7%	Plans to appoint U.S. leadership to drive AI infrastructure expansion strategy.
Nov 06	AI integration LOI	Positive	-18.0%	LOI to integrate LV Grid team and IP into Grid AI for hyperscaler market.
Oct 30	GridAI acquisition	Positive	-0.7%	Acquisition of GRID AI shifting focus from biotech to grid-edge AI orchestration.

Pattern Detected

Recent AI- and GridAI-related announcements generally saw negative price reactions, while the branding/name-change step coincided with a positive move.

Recent Company History

Over the last two months, Entero has been repositioning around GridAI and grid-edge AI orchestration. The October GridAI acquisition and subsequent AI data-center initiatives (news IDs 926419, 931484, 935582, 938433) all focused on scaling AI infrastructure but drew mostly negative near-term reactions. Today’s name and ticker change (news ID 941561) formalizes the strategic shift toward GridAI Technologies Corp. and aligns the corporate identity with the acquired grid-edge AI platform, without altering legal structure or reporting obligations.

Market Pulse Summary

The stock moved +5.3% in the session following this news. A strong positive reaction aligns with the...

Analysis

The stock moved +5.3% in the session following this news. A strong positive reaction aligns with the formalization of Entero’s pivot to grid-edge AI under the GridAI Technologies Corp. name. The stock had previously sold off on several AI expansion updates despite seemingly constructive news. A move of 5.28% on heavy volume of 896,051 shares may reflect investors’ preference for clear, identity-defining milestones, but past divergences suggest sentiment can shift quickly if execution or financing risks resurface.

Key Terms

distributed energy resources, battery energy storage systems, machine learning, edge analytics

4 terms

distributed energy resources technical

"manage load and distributed energy resources including battery energy"

Small, local sources and devices that generate, store or manage electricity near where it’s used—examples include rooftop solar panels, batteries, electric vehicles, smart thermostats and backup generators. They matter to investors because they reshape how power is produced, sold and paid for: they can lower costs, create new revenue streams, change regulation and require grid upgrades, so they affect company profits, risk profiles and growth opportunities much like dozens of small engines changing how a single factory runs.

battery energy storage systems technical

"distributed energy resources including battery energy storage systems."

Large, grid-connected rechargeable battery systems that store electricity for later use, like a giant household battery for cities or power plants. They matter to investors because they help balance supply and demand, enable more renewable energy, reduce outage risk, and create revenue through services such as selling stored power at peak times or participating in grid stability programs, while requiring upfront capital and having performance limits tied to lifespan and degradation.

machine learning technical

"using AI, machine learning and edge analytics by orchestrating supply"

Machine learning is a set of computer programs that learn patterns from large amounts of data and improve their predictions or decisions over time, like a recipe that gets better each time it’s adjusted based on taste tests. For investors it matters because these systems can speed up analysis, spot trends or risks humans might miss, automate routine work, and potentially create competitive advantages or cost savings that affect a company’s performance.

edge analytics technical

"AI, machine learning and edge analytics by orchestrating supply and demand"

Edge analytics is the practice of processing and analyzing data where it is created—on devices, sensors or local computers—rather than sending everything to a central server. For investors it matters because it can cut operating costs and delays, improve privacy and reliability, and enable new real-time services or products, all of which affect a company’s competitiveness, capital needs and potential revenue growth.

AI-generated analysis. Not financial advice.

BOCA RATON, FL / ACCESS Newswire / November 28, 2025 / Entero Therapeutics, Inc. (NASDAQ:ENTO) (the "Company") today announced that it will change its name to GridAI Technologies Corp., effective at 12:01 Eastern Time on Monday, December 1, 2025. The name change closely aligns the Company's business following its acquisition of 100% of GRID AI Corp ("GRID AI"), a grid-edge, AI-driven software and controls platform that enables utilities, retail energy providers, and large power users to dynamically manage load and distributed energy resources including battery energy storage systems. In connection with the name change, the Company will change its ticker symbol to "GRDX". The Company's common stock will commence trading on the Nasdaq Capital Market exchange under the new name and trading symbol on December 1, 2025.

"This marks the beginning of a new chapter for the business," said Jason Sawyer, Interim Chief Executive Officer of GridAI Technologies Corp. "Our mission is to enhance grid-edge intelligence using AI, machine learning and edge analytics by orchestrating supply and demand in real time, creating a more reliable, resilient, and transactive grid -now supported with our public-company platform - and this name change reflects that commitment."

The name and future ticker change do not affect the Company's legal structure, business operations, or existing financial reporting obligations. Shareholders are not required to take any action in connection with the change.

Further updates will be provided via regular press releases and regulatory filings.

About Entero Therapeutics, Inc. (NASDAQ:ENTO)
Entero Therapeutics, Inc. is a publicly listed company on Nasdaq. The Company is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The Company's programs address significant unmet needs in GI health and comprise development of Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency. Following completion of the GRID AI acquisition, the Company intends to continue these prior operations and to also operate GRID AI as a wholly owned subsidiary and pursue opportunities at the intersection of AI and energy infrastructure.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding strategic benefits of the acquisition, market opportunities, product capabilities, stockholder approval of the transaction, Nasdaq's approval of an initial listing application, if any, and future operating results. These statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially. Important factors include, among others, our business strategy; the risk that regulatory or third-party approvals are delayed or not obtained; integration challenges; market adoption; competitive dynamics; macroeconomic and energy-market conditions; and other risks detailed from time to time in the Company's SEC filings. The Company undertakes no obligation to update forward-looking statements.

Investor & Media Contacts:
Entero Investor Relations
investors@enterothera.com

SOURCE: Entero Therapeutics, Inc.

View the original press release on ACCESS Newswire

FAQ

When will Entero Therapeutics change its name to GridAI Technologies and ticker to GRDX?

The name and ticker change take effect at 12:01 ET on December 1, 2025, with trading under GRDX starting that day.

What does the acquisition of GRID AI mean for ENTO shareholders?

The company acquired 100% of GRID AI Corp; the announcement says this aligns the business to grid-edge AI operations.

Do shareholders need to take any action for ENTO to become GRDX?

No action is required by shareholders; the company stated shareholders do not need to take any steps.

Will the company's legal structure or reporting change after the name switch to GridAI (GRDX)?

The company said the name and ticker change do not affect legal structure, business operations, or financial reporting obligations.

What markets and customers does GRID AI serve following Entero's acquisition?

GRID AI provides grid-edge AI software and controls for utilities, retail energy providers, and large power users.

Where will investors find future updates about GridAI Technologies (GRDX)?

The company will provide further updates via regular press releases and regulatory filings.